Potassium Salt of Fullerenylpenta-N-Dihydroxytyrosine Effects on Type 2 Diabetes Mellitus Therapeutic Targets


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

It was shown for the first time that pentaamino acid derivative of fullerene C60 (potassium salt of fullerenylpenta-N-dihydroxytyrosine) affects three targets of type 2 diabetes mellitus. It competitively inhibits the enzymes aldose reductase and sorbitol dehydrogenase and also has an antiglycation effect on bovine serum albumin. The inhibition constants for these enzymes were calculated.

作者简介

Yu. Soldatova

Institute of Problems of Chemical Physics, Russian Academy of Sciences; Moscow Region State University

编辑信件的主要联系方式.
Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432; Moscow

R. Kotelnikova

Institute of Problems of Chemical Physics, Russian Academy of Sciences

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432

A. Zhilenkov

Institute of Problems of Chemical Physics, Russian Academy of Sciences

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432

I. Faingold

Institute of Problems of Chemical Physics, Russian Academy of Sciences; Moscow Region State University

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432; Moscow

P. Troshin

Institute of Problems of Chemical Physics, Russian Academy of Sciences; Skolkovo Institute of Science and Technology

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432; Moscow, 143025

M. Kozlova

Moscow Region State University

Email: soldatovayv@gmail.com
俄罗斯联邦, Moscow

D. Areshidze

Institute of Problems of Chemical Physics, Russian Academy of Sciences; Moscow Region State University

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432; Moscow

S. Aldoshin

Institute of Problems of Chemical Physics, Russian Academy of Sciences

Email: soldatovayv@gmail.com
俄罗斯联邦, Chernogolovka, Moscow oblast, 142432

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2019